NDC 54868-2145

NDC 54868-2145

NDC 54868-2145 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 54868-2145
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 54868-2145-9 [54868214509]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-11
Inactivation Date2019-09-24

NDC 54868-2145-7 [54868214507]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1993-06-29
Marketing End Date2011-07-26

NDC 54868-2145-5 [54868214505]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-06-29
Inactivation Date2019-09-24

NDC 54868-2145-8 [54868214508]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1993-06-29
Marketing End Date2011-07-26

NDC 54868-2145-2 [54868214502]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-06-29
Inactivation Date2019-09-24

NDC 54868-2145-0 [54868214500]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-06-29
Inactivation Date2019-09-24

NDC 54868-2145-3 [54868214503]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-06-29
Inactivation Date2019-09-24

NDC 54868-2145-4 [54868214504]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-06-29
Inactivation Date2019-09-24

NDC 54868-2145-6 [54868214506]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072926
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-06-29
Inactivation Date2019-09-24

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.